Annals of the Rheumatic Diseases Issues Research Articles in April 2022 Edition
March 11, 2022
March 11, 2022
LONDON, England, March 11 -- Annals of the Rheumatic Diseases, a peer-reviewed journal that says it covers rheumatology, including musculoskeletal conditions, arthritic disease and connective tissue disorders, published research articles, including the following topics, in its April 2022 edition:
RHEUMATOID ARTHRITIS:
* Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled . . .
RHEUMATOID ARTHRITIS:
* Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled . . .